Attempts have been made to improve skeletal muscle function and delay age-related muscle atrophy by pharmacological antagonism of the ACE-Ang II-AT1R pathways using AT1R antagonists or ACE inhibitors (ACEIs). Here, AGTR1 is linked to age.